Lim, Hyunji
Park, Soo Jin
Paik, Haerin
Mun, Jaehee
Lee, Eun Ji
Lee, Seungmee
Lim, Whasun
Song, Gwonhwa
Shim, Seung-Hyuk
Lee, Chae Hyeong
Yim, Ga Won
Kim, Hee Seung https://orcid.org/0000-0001-6876-8671
,
Funding for this research was provided by:
Medifine
Dalim
Article History
Received: 2 December 2020
Accepted: 7 July 2021
First Online: 21 July 2021
Declarations
:
: The IRB at Seoul National University Hospital approved the PRAHA-2 trial in October 2020 (No. 2008-059-1147), and the IRB at Dongguk University Ilsan Hospital approved it in April 2021 (No. DUIH 2021-03-004). The written, informed consent to participate will be obtained from all participants.
: Not applicable
: The authors declare that they have no competing interests.